immunotherapy | dermcity

Nov 182 min read

SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition

In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...

Apr 292 min read

Melanoma vaccine enters international trial phase

Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...

Aug 21, 20232 min read

Combination therapy of benefit in metastatic melanoma

A new finding suggests that a combination of immunotherapies will help patients with aggressive melanoma resistant to PD-1 inhibitors....

Jan 23, 20232 min read

Gene mutations could point to new treatments for scleroderma

A study from the University of Alberta has identified genetic mutations in scleroderma patients, a finding that may lead to new...

Apr 4, 20222 min read

High-risk melanoma: Use of targeted therapies up, sentinel lymph node dissection down

Data collected from 21 melanoma referral centres in the U.S., Europe, and Australia reveals that, over the last five years, the use of...

Jul 7, 20211 min read

VIDEO: New study highlights need for treatment options for diffuse cutaneous systemic sclerosis

A new study suggests that with current immunosuppressive therapies, 20% of people with early or at-risk dcSSc experienced worsening of skin.

Apr 14, 20211 min read

VIDEO: Study finds 10 skin-related conditions associated with immune checkpoint inhibitors

An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.

Feb 10, 20211 min read

VIDEO: Fecal microbiota transplant may help melanoma patients respond to immunotherapy

A proof-of-principle study has found that fecal transplants may help advanced melanoma patients respond to immunotherapy better.

Featured Posts